Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 31 Show results per page	View Search Criteria \| Help With Results

Last Modified: 3/16/2006 First Published: 8/1/2001


1.		Phase III Randomized Study of Decitabine Versus Supportive Care in Patients With Advanced Myelodysplastic Syndromes

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Pharmaceutical / Industry				SUPERGEN-D-0007 ABCCC-010303, NCT00043381

Last Modified: 7/1/2000


2.		Phase I/II Study of Chemotherapy with High-Dose Decitabine, Busulfan, and Cyclophosphamide with Allogeneic Stem Cell Transplantation in Patients With Hematologic Malignancies (Summary Last Modified 07/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				15 to 55				NCI				MDA-DM-94064 NCI-G96-0999, NCT00002831

Last Modified: 7/12/2007


3.		Phase I/II Trial of Decitabine and Allogeneic Peripheral Blood Stem Cells Transplantation in Patients With Relapse Post Allogeneic Bone Marrow Transplantation (Summary Last Modified 07/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				60 and under				NCI				MDA-DM-94077 NCI-G96-1000, NCT00002832

Last Modified: 11/1/1994


4.		Phase II Study of Decitabine in Hormone-Refractory Stage D2 Prostate Cancer (Summary Last Modified 11/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				over 18								NCI-94-C-0002A NCI-CPB-332

Last Modified: 7/12/2007 First Published: 8/1/1998


5.		Phase II Study of Decitabine for Myelodysplastic Syndromes (Summary Last Modified 12/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				15 and over				NCI				MSKCC-98017 NCI-G98-1444, NCT00003361

Last Modified: 5/1/1989


6.		Phase II Chemotherapy with 5-Aza-dCyd in Patients with Recurrent or Metastatic Squamous Cell Cancer of the Uterine Cervix (Summary Last Modified 05/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 to 75								EORTC-55857


7.		Phase II Trial of 5-Aza-2'-deoxycytidine in Patients with Advanced Squamous Cell Carcinoma, Adenocarcinoma, and Large Cell Carcinoma of the Lung

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				75 and under								EORTC-16851C


8.		Phase II Chemotherapy with 5-AZA-2'-Deoxycytidine in Patients with Relapsed or Refractory Stage III/IV Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 15								EORTC-20861


9.		Phase II Study of Chemotherapy with 5-Aza-2'-Deoxycytidine in Patients with Advanced Epithelial Cancer of the Ovary

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				70 and under								EORTC-16851G

Last Modified: 5/1/1988


10.		Phase II Chemotherapy with 5-Aza-2'-deoxycytidine in Patients with Nonseminomatous Testicular or Extragonadal Germ Cell Tumors That Are Progressive, Measurable, and Metastatic (Summary Last Modified 05/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				any age								EORTC-30871

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute